JANX vs MKTX · rev $10.3M vs P/E 13, rev $451.8M
Janux Therapeutics Inc (JANX) versus MarketAxess Holdings Inc (MKTX) — a side-by-side from cached financials, not a winner call.
Janux Therapeutics Inc (JANX) is a biotechnology company listed on US.
MarketAxess Holdings Inc (MKTX) is a capital markets company listed on US.
Latest reported JANX revenue for 2026-06-30 was $10.3M. Net income was -$22.0M. JANX currently screens at market cap $1.49B.
Latest reported MKTX revenue for 2026-06-30 was $451.8M. Net income was $146.0M. Revenue was up 93.6% from 2026-03-31 to 2026-06-30. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
JANX currently screens at market cap $1.49B. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
Not investment advice. Open the JANX and MKTX stock pages for the full models.
Not investment advice.